David Jonathan Powell, Chief Scientific Officer at Summit Therapeutics Inc. (SMMT), sold 86,564 shares at $4.44 ($381K) on 2020-11-30, disclosed to the SEC on 2020-12-01.
Open-market sale of $381k SMMT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.39 | 29,569 | $130K | 34.0% |
| 2 | $4.39 | 29,569 | $130K | 34.0% |
| 3 | $4.44 | 13,713 | $61K | 16.0% |
| 4 | $4.44 | 13,713 | $61K | 16.0% |
| Total | $4.41 avg | 86,564 | $381K | 100% |